These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2052857)
1. Immunogenicity and protective efficacy of affinity-purified Plasmodium falciparum exoantigens in Aotus nancymai monkeys. James MA; Fajfar-Whetstone CJ; Kakoma I; Buese MM; Clabaugh GW; Hansen R; Ristic M Trop Med Parasitol; 1991 Mar; 42(1):49-54. PubMed ID: 2052857 [TBL] [Abstract][Full Text] [Related]
2. Induction of protective immunity to Plasmodium falciparum in Saimiri sciureus monkeys with partially purified exoantigens. James MA; Kakoma I; Ristic M; Cagnard M Infect Immun; 1985 Sep; 49(3):476-80. PubMed ID: 3897052 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum. Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894 [TBL] [Abstract][Full Text] [Related]
4. Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys. Siddiqui WA; Tam LQ; Kan SC; Kramer KJ; Case SE; Palmer KL; Yamaga KM; Hui GS Infect Immun; 1986 Apr; 52(1):314-8. PubMed ID: 3514459 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111 [TBL] [Abstract][Full Text] [Related]
6. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum. Enders B; Hundt E; Knapp B Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721 [TBL] [Abstract][Full Text] [Related]
7. Application of exoantigens of Babesia and Plasmodium in vaccine development. James MA Trans R Soc Trop Med Hyg; 1989; 83 Suppl():67-72. PubMed ID: 2696163 [TBL] [Abstract][Full Text] [Related]
8. Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans). Collins WE; Pappaioanou M; Anders RF; Campbell GH; Brown GV; Kemp DJ; Broderson JR; Coppel RL; Skinner JC; Procell PM Am J Trop Med Hyg; 1988 Mar; 38(2):268-82. PubMed ID: 3281493 [TBL] [Abstract][Full Text] [Related]
9. Immunization of owl monkeys with a combination of Plasmodium falciparum asexual blood-stage synthetic peptide antigens. Ruebush TK2nd ; Campbell GH; Moreno A; Patarroyo ME; Collins WE Am J Trop Med Hyg; 1990 Oct; 43(4):355-66. PubMed ID: 2240363 [TBL] [Abstract][Full Text] [Related]
10. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection. Makobongo MO; Keegan B; Long CA; Miller LH J Infect Dis; 2006 Mar; 193(5):731-40. PubMed ID: 16453270 [TBL] [Abstract][Full Text] [Related]
11. Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum. Collins WE; Anders RF; Ruebush TK; Kemp DJ; Woodrow GC; Campbell GH; Brown GV; Irving DO; Goss N; Filipski VK Am J Trop Med Hyg; 1991 Jan; 44(1):34-41. PubMed ID: 1996739 [TBL] [Abstract][Full Text] [Related]
12. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant. Inselburg J; Bathurst IC; Kansopon J; Barr PJ; Rossan R Infect Immun; 1993 May; 61(5):2048-52. PubMed ID: 8478093 [TBL] [Abstract][Full Text] [Related]
13. Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins. Knapp B; Hundt E; Enders B; Küpper HA Infect Immun; 1992 Jun; 60(6):2397-401. PubMed ID: 1587607 [TBL] [Abstract][Full Text] [Related]
14. Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line. Baruch DI; Gamain B; Barnwell JW; Sullivan JS; Stowers A; Galland GG; Miller LH; Collins WE Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3860-5. PubMed ID: 11904437 [TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity against experimental infection with malaria using synthetic peptides. Patarroyo ME; Romero P; Torres ML; Clavijo P; Moreno A; Martínez A; Rodríguez R; Guzman F; Cabezas E Nature; 1987 Aug 13-19; 328(6131):629-32. PubMed ID: 3302727 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66. Millet P; Campbell GH; Sulzer AJ; Grady KK; Pohl J; Aikawa M; Collins WE Am J Trop Med Hyg; 1993 Mar; 48(3):424-31. PubMed ID: 7682382 [TBL] [Abstract][Full Text] [Related]
17. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity. Inselburg J; Bathurst IC; Kansopon J; Barchfeld GL; Barr PJ; Rossan RN Infect Immun; 1993 May; 61(5):2041-7. PubMed ID: 8478092 [TBL] [Abstract][Full Text] [Related]
18. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys. Herrera S; Herrera MA; Certa U; Corredor A; Guerrero R Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():423-8. PubMed ID: 1343722 [TBL] [Abstract][Full Text] [Related]
19. A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys. Ridley RG; Takacs B; Etlinger H; Scaife JG Parasitology; 1990 Oct; 101 Pt 2():187-92. PubMed ID: 2263413 [TBL] [Abstract][Full Text] [Related]
20. Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Holder AA; Freeman RR; Nicholls SC Parasite Immunol; 1988 Nov; 10(6):607-17. PubMed ID: 3064031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]